Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ALX Oncology Holdings Inc. - Common Stock
(NQ:
ALXO
)
1.750
+0.140 (+8.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ALX Oncology Holdings Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
ALX Oncology Announces September Investor Conference Participation
August 31, 2023
From
ALX Oncology
Via
GlobeNewswire
4 Analysts Have This to Say About ALX Oncology Holdings
August 11, 2023
Via
Benzinga
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
August 10, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
July 21, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About ALX Oncology Holdings
May 12, 2023
Via
Benzinga
Recap: ALX Oncology Holdings Q1 Earnings
May 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 06, 2023
Via
Benzinga
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
July 06, 2023
Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
Via
Benzinga
ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer
June 26, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
May 11, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces First Patient Dosed in Phase 2 Investigator-Sponsored Trial of Evorpacept in Patients with Ovarian Cancer
May 09, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
April 25, 2023
From
ALX Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer
March 13, 2023
From
ALX Oncology
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
March 09, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer
February 16, 2023
From
ALX Oncology
Via
GlobeNewswire
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
January 13, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 10, 2023
Via
Benzinga
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023
January 05, 2023
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
ALX Oncology
Via
GlobeNewswire
AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday
December 23, 2022
U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
ALX Oncology Announces Initial Data from ASPEN-05 Study of Evorpacept in Combination with Azacitidine and Venetoclax, Demonstrating Tolerability and Preliminary Activity in Patients with Acute Myeloid Leukemia
December 12, 2022
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Appoints Scott Garland to its Board of Directors
November 29, 2022
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
November 08, 2022
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology to Present New Clinical Data on Evorpacept in Acute Myeloid Leukemia at 64th ASH Annual Meeting
November 03, 2022
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Upcoming Investor Conference Participation
November 02, 2022
From
ALX Oncology
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today